Company Overview

Indegene Limited is the strategic operating partner to the global life sciences industry, orchestrating commercial, medical, R&D, and safety operations across the product lifecycle. Trusted by the world’s top 20 biopharma companies, Indegene helps run complex, highly regulated workflows at global scale. Indegene combines deep life sciences expertise with AI-embedded platforms and governed operating models to improve speed, consistency, and compliance across mission-critical operations. By integrating technology into how work is executed and scaled, Indegene enables life sciences organizations to deliver measurable outcomes in regulated environments.

Company Announcements

Our CEO’s Message

Extending our strong start to FY27, Q2 revenue grew 5.6% sequentially in INR, our fifth successive quarter above 5%. Growth was broad-based, driven by expansion across our top 5 and top 20 accounts and an increase in the number of $1 million+ clients to 59.

We recorded significant deal wins in GenAl-enabled transformation and upstream engagements. With a healthy pipeline, sustained deal momentum and favourable industry tailwinds, we expect growth and margin expansion to come together in the second half.

Manish Gupta

Chairman and Chief Executive Officer

Manish Gupta

Our CFO’s Message

Despite the annual wage increase that takes effect in our second quarter. EBITDA margin remained stable at 16.7%, a marked improvement on historical Q2 margin trends. Profit after tax grew 10% YoY to INR 1.123

With the wage increase now fully reflected in our cost base, we expect EBITDA to grow faster than revenue in the coming quarters. In addition, higher yields on our investments and lower amortization should help PAT margin expand faster than EBITDA margin.

Suhas Prabhu

Chief Financial Officer

Suhas Prabhu
Q2 FY26-27 Quarterly Results

₹ 11,223 M

Revenue

39.5%

YoY Revenue Growth

₹ 1,123 M

PAT

+10.0%

YoY PAT Growth

59

Clients with $1 Mn+ Revenue

5,952

Total Employees

28.8%

Healthcare Expertise

46.8%

Women Employees
Indegene is a new category
not a better version of an old one
E mbedded Revenue Partner
$79.6K
Revenue/Employee - Highest in Industry
  • Operate in clients' revenue-generating engine: Commercial & Med teams behind launches, brands & growth
  • Sit on growth-side budgets, not IT cost budgets; less exposed to cost-cutting cycles
  • Productivity-benefit gets redeployed as increased volume: personalized content and more channels
D eep Domain Expertise
~29%
Employees From Healthcare
  • With over 27 years of experience in life sciences, we are deeply integrated in client workflows
  • Manage critical workflows requiring high degree of domain expertise and regulatory compliance
  • Judgment-intensive work where GenAI compounds domain knowledge rather than replacing it
G enAI Disruptor
10+
Years of delivering AI
  • Pharma companies face complexity explosion (content volume & regulatory compliance) & fragmented non-standardized models resulting in efforts to centralize operations
  • Our AI-enabled solutions engage at enterprise level (not brand-by-brand) to re-engineer & re-imagine end-to-end processes, thus accelerating this transformation & taking wallet share from incumbents
  • GenAI price deflation pressures large incumbents but provides growth headroom for us at our current scale
E ngagement Model
~60%
Revenue outcome-aligned*
  • Global delivery model with multi-geography governance & standardization generating productivity at scale
  • Majority revenue is outcome-aligned — paid for work delivered and value created
  • Efficiency gains flow to the bottom line, creating incentive to adopt and scale newer technologies faster

 

*refers to output-based engagements including managed services component in hybrid contracts but excluding pure FTE or T&M contracts

Quick Links